Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
29.25
-3.75 (-11.36%)
At close: Jun 18, 2024, 4:00 PM
29.41
+0.16 (0.55%)
After-hours: Jun 18, 2024, 5:51 PM EDT

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $224.00M in the twelve months ending March 31, 2024, with 133.90% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $69.22M with 119.07% year-over-year growth. In the year 2023, Mirum Pharmaceuticals had annual revenue of $186.37M with 141.85% growth.

Revenue (ttm)
$224.00M
Revenue Growth
+133.90%
P/S Ratio
6.15
Revenue / Employee
$848,477
Employees
264
Market Cap
1.38B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition